News

Metyrapone Rapidly Reduces Cortisol Levels in Cushing’s Syndrome Patients, Real-Life Study Shows

Treatment with metyrapone rapidly reduces cortisol levels in Cushing’s syndrome patients and keeps them low over the long term, a real-life study shows. The study, “Metyrapone treatment in Cushing’s syndrome: a real-life study,” was published in the journal Endocrine. Cushing’s syndrome is a condition where patients have too much cortisol…

Laparoscopic Adrenalectomy Is Effective and Safe for Treating Cushing’s Syndrome, Study Finds

Laparoscopic adrenalectomy — the removal of the adrenal glands through tiny holes in the abdomen — is a safe and effective method for treating certain patients with Cushing’s syndrome, according to researchers. Their study, “Effectiveness of unilateral laparoscopic adrenalectomy in ACTH-independent hypercortisolaemia and subclinical Cushing’s syndrome — a retrospective…

Temozolomide Partially Effective for Aggressive Pituitary Tumors, But More Study Needed, Case Report Shows

Temozolomide — an oral chemotherapy treatment — may be partially effective for Cushing’s disease patients with aggressive pituitary tumors that do not respond to conventional therapies, a case report suggests. However, despite initial tumor stabilization with temozolomide treatment, the patient described in the case report died shortly thereafter, indicating a…